Werner Cautreels's most recent trade in Traws Pharma Inc. was a trade of 23,000 Stock Option (right to purchase) done . Disclosure was reported to the exchange on June 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Traws Pharma Inc. | Werner Cautreels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2025 | 23,000 | 23,000 | - | - | Stock Option (right to purchase) | |
| Traws Pharma Inc. | Werner Cautreels | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.01 per share. | 18 Feb 2025 | 96,348 | 104,348 (0%) | 0% | 0.0 | 963 | Common Stock |
| Traws Pharma Inc. | Werner Cautreels | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 96,348 | 0 | - | - | Pre-Funded Warrant (right to buy) | |
| Traws Pharma Inc. | Werner Cautreels | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Dec 2024 | 96,348 | 96,348 | - | - | Series A Warrant (right to buy) | |
| Traws Pharma Inc. | Werner Cautreels | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Dec 2024 | 96,348 | 96,348 | - | - | Pre-Funded Warrant (right to buy) | |
| Traws Pharma Inc. | Werner Cautreels | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 200,000 | 200,000 (0%) | 0% | - | Common Stock |